Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,254,490
-$1,323,795 QoQ
Shares Held
525,449
-37.7% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 316 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. BCRX ranks #24 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in BCRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,254,490 | 525,449 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $6,578,285 | 843,370 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $8,594,738 | 1,132,377 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $14,194,483 | 1,584,206 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $7,991,871 | 1,065,583 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,567,305 | 474,376 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,386,179 | 577,129 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $4,619,739 | 747,531 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,366,905 | 269,076 | Shares | Sole | 2024-12-26 | |
| 2023-12-31 | $3,279,746 | 547,537 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $4,308,285 | 608,515 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,445,863 | 631,515 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $9,121,281 | 794,537 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $9,754,956 | 774,203 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,808,841 | 549,040 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,256,567 | 200,281 | Shares | Defined | 2022-05-11 | |
| 2021-09-30 | $2,674,012 | 186,083 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,122,252 | 197,486 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,667,554 | 163,968 | Shares | Defined | 2021-05-12 | |
| 2020-09-30 | $647,146 | 188,124 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $902,919 | 189,689 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $313,070 | 156,535 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||